9 METERS BIOPHARMA, INC.NMTRQCash flow

Market cap
$1.45K
P/E ratio
2016/122017/122018/122019/122020/122021/122022/12
Stock-based compensation1143524
Cash from operations -8-4-15,169,330-17,967,992-19,409,786-29,478,275-37,243,217
Capital expenditures---13,943-11,934-2,543-12,476-2,842
Cash from investing ---13,943-11,934-3,186,997-2,430,641-2,842
Cash from financing 1032117564120
Free cash flow--